Skip to main content
. Author manuscript; available in PMC: 2009 Feb 12.
Published in final edited form as: J Gerontol A Biol Sci Med Sci. 2008 Oct;63(10):1034–1042. doi: 10.1093/gerona/63.10.1034

Table 6.

Changes in Organ Weight and Cardiac Fibrosis

LS LSG HS HSG HSH
Heart W/TL 0.34 ± 0.01 0.33 ± 0.02 0.42 ± 0.1* 0.32 ± 0.01 0.43 ± 0.3
Kidney W/TL 0.71 ± 0.04 0.65 ± 0.04 0.98 ± 0.05* 0.82 ± 0.04 0.83 ± 0.06
Lung W/TL 0.42 ± 0.04 0.40 ± 0.04 0.54 ± 0.06 0.43 ± 0.05 0.52 ± 0.04
Cardiac hydroxyproline 5.2 ± 0.3 5.1 ± 0.2 9.2 ± 0.2* 7.4 ± 0.3 9.1 ± 0.3*
Cardiac perivascular area fibrosis 1.19 ± 0.04 1.17 ± 0.02 1.45 ± 0.1* 1.3 ± 0.03 1.40 ± 0.*

Notes: HW (g heart weight), KW (g kidney weight), and LW (g lung weight) are relative to tibial length (TL) in centimeters. Perivascular area fibrosis is expressed as microns squared. Hydroxyproline is expressed as milligrams per milligrams of total protein. Data are presented as means ± standard error of the mean; n = 12 per group.

LS = low-salt diet; LSG = low salt + grape powder diet; HS = high-salt diet; HSG = high salt + grape powder diet; HSH = high salt + vasodilator hydralazine diet.

*

At least p < .05 vs LS and LSG.

p < .05 vs LS, LSG, HS.

HHS Vulnerability Disclosure